These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tissue distribution of mexiletine enantiomers in rats. Igwemezie L; Beatch GN; Walker MJ; McErlane KM Xenobiotica; 1991 Sep; 21(9):1153-8. PubMed ID: 1788983 [TBL] [Abstract][Full Text] [Related]
7. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias. Barrett TD; Hayes ES; Walker MJ Eur J Pharmacol; 1995 Oct; 285(3):229-38. PubMed ID: 8575508 [TBL] [Abstract][Full Text] [Related]
8. Quinacainol, a new antiarrhythmic with class I antiarrhythmic actions in the rat. Howard PG; MacLeod BA; Walker MJ Eur J Pharmacol; 1992 Aug; 219(1):1-8. PubMed ID: 1397036 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Pugsley MK; Penz WP; Walker MJ; Wong TM Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979 [TBL] [Abstract][Full Text] [Related]
10. The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat. Curtis MJ; Walker MJ Br J Pharmacol; 1986 Sep; 89(1):137-47. PubMed ID: 3801768 [TBL] [Abstract][Full Text] [Related]
11. Ventricular arrhythmia incidence in the rat is reduced by naloxone. Pugsley MK; Hayes ES; Wang WQ; Walker MJ Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674 [TBL] [Abstract][Full Text] [Related]
12. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical. Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571 [TBL] [Abstract][Full Text] [Related]
14. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker. Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997 [TBL] [Abstract][Full Text] [Related]
15. Tacrine inhibits ventricular fibrillation induced by ischaemia and reperfusion and widens QT interval in rat. Rees SA; Curtis MJ Cardiovasc Res; 1993 Mar; 27(3):453-8. PubMed ID: 8490946 [TBL] [Abstract][Full Text] [Related]
16. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360. Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718 [TBL] [Abstract][Full Text] [Related]
17. Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine. Lynch JJ; Nelson SD; MacEwen SA; Driscoll EM; Lucchesi BR J Pharmacol Exp Ther; 1987 May; 241(2):741-9. PubMed ID: 2883307 [TBL] [Abstract][Full Text] [Related]
18. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat. Diederich KW; Boyksen D Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225 [No Abstract] [Full Text] [Related]
19. Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR Pharmacology; 1987; 35(4):181-93. PubMed ID: 3118399 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of the enantiomers of mexiletine in humans. Igwemezie L; Kerr CR; McErlane KM Xenobiotica; 1989 Jun; 19(6):677-82. PubMed ID: 2763576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]